Canadian recommendations for the use of SGLT2i and mineralocorticoid receptor antagonists in the management of heart failure with mildly reduced or preserved ejection fraction

29 August 2026 (17:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Pharmacologic management of heart failure with mildly reduced or preserved ejection fraction Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology